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ABSTRACT
The scleroderma group of diseases is characterized by the presence of hard skin. The 
pathogenesis of scleroderma include excessive production of collagen and extracellular 
matrix by fibroblasts, not only in the skin but also in vital organs and around blood vessels 
with endothelial cell injury. Systemic Sclerosis (SSc) usually constitutes less than 1% of most 
pediatric rheumatology clinic populations. Females are affected much more commonly 
than males.
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The scleroderma group of diseas-
es is characterized by the presence 
of hard skin. The pathogenesis of 
scleroderma include excessive pro-
duction of collagen and extracellu-
lar matrix by ﬁbroblasts, not only in 
the skin but also in vital organs and 
around blood vessels with endothe-
lial cell injury (1). Systemic Sclerosis 
(SSc) usually constitutes less than 
1% of most pediatric rheumatology 
clinic populations (2). Females are 
affected much more commonly than 
males.
The earliest skin manifestation of 
SSc is nonpitting inflammatory ede-
ma of the hands, which results in re-
strictive range of motion. With time, 
this progress to skin thickening with 
an inability to lift the skin (3).
Progressive thickening and tight-
ness of the skin result in joint con-
tractures and an inability to fully 
open the mouth. Other skin man-
ifestations include abnormal nail 
folds and calcinosis, telangiectasia, 
areas of hyperpigmentation and hy-
popigmentation (4).
Musculoskeletal involvement is 
common. Fibrosis of the joint cap-
sule and thickening of the synovium 
results in joint contractures, a prob-
lem exacerbated by the thickened 
and tight skin around the joint.
Gastrointestinal involvement is a 
major cause of morbidity. The ma-
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Figure 1. Patient with sclerodermica 
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jor current cause of mortality results from pulmonary 
involvement.
Renal disease, formerly the major cause of mortality, is 
now more manageable. Th e heart is also commonly af-
fected.
Clinical methods to quantify skin thickening have been 
validated in adults but not in children (3).
Here is described very simple and useful sign to eval-
uate thickening and tightness of the skin in children as 
Farhad’s sign:
In order to examine conjunctiva for anemia in children, 
we have to pull the lower eyelid downwardly. It is easi-
ly done in healthy people (5, 6) however; it wouldn’t be 
done in patients with sclerodermia (Figure 1, 2)
Th is is a valuable fi nding that can be seen in all patients 
with systemic sclerosis. We name that Farhad’s sign and 
use it in clinical examination of all suspected scleroder-
mia patients; and recommend it to all young physicians 
at practice.
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Figrue 2. Patient with sclerodermia
